These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30115992)

  • 61. Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.
    Queenan AM; Dowling DJ; Cheng WK; Faé K; Fernandez J; Flynn PJ; Joshi S; Brightman SE; Ramirez J; Serroyen J; Wiertsema S; Fortanier A; van den Dobbelsteen G; Levy O; Poolman J
    Vaccine; 2019 Jan; 37(1):80-89. PubMed ID: 30478007
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children.
    Mahon BP; Brady MT; Mills KH
    J Infect Dis; 2000 Jun; 181(6):2087-91. PubMed ID: 10837200
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PTX Instructs the Development of Lung-Resident Memory T Cells in
    Tomas J; Koo Y; Popoff D; Arce-Gorvel V; Hanniffy S; Gorvel JP; Mionnet C
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564636
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of Toll-like receptor-4 in pertussis vaccine-induced immunity.
    Banus S; Stenger RM; Gremmer ER; Dormans JA; Mooi FR; Kimman TG; Vandebriel RJ
    BMC Immunol; 2008 May; 9():21. PubMed ID: 18498620
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model.
    Kang KR; Huh DH; Kim JA; Kang JH
    BMC Immunol; 2021 Oct; 22(1):68. PubMed ID: 34641798
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.
    Salcedo-Rivillas C; Debrie AS; Miyaji EN; Ferreira JM; Raw I; Locht C; Ho PL; Mielcarek N; Oliveira ML
    Clin Vaccine Immunol; 2014 Jul; 21(7):972-81. PubMed ID: 24807055
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm.
    Li R; Lim A; Phoon MC; Narasaraju T; Ng JK; Poh WP; Sim MK; Chow VT; Locht C; Alonso S
    J Virol; 2010 Jul; 84(14):7105-13. PubMed ID: 20444902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.
    Barnard A; Mahon BP; Watkins J; Redhead K; Mills KH
    Immunology; 1996 Mar; 87(3):372-80. PubMed ID: 8778021
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.
    David S; van Furth R; Mooi FR
    Vaccine; 2004 May; 22(15-16):1892-8. PubMed ID: 15121300
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bordetella pertussis from functional genomics to intranasal vaccination.
    Locht C; Antoine R; Raze D; Mielcarek N; Hot D; Lemoine Y; Mascart F
    Int J Med Microbiol; 2004 Apr; 293(7-8):583-8. PubMed ID: 15149035
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Live pertussis vaccines: will they protect against carriage and spread of pertussis?
    Locht C
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S96-S102. PubMed ID: 28341014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract.
    Chasaide CN; Mills KHG
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33096737
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
    Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA
    Front Immunol; 2019; 10():1520. PubMed ID: 31333656
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis.
    Warfel JM; Zimmerman LI; Merkel TJ
    Clin Vaccine Immunol; 2016 Jan; 23(1):47-54. PubMed ID: 26561389
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
    Wolf MA; Boehm DT; DeJong MA; Wong TY; Sen-Kilic E; Hall JM; Blackwood CB; Weaver KL; Kelly CO; Kisamore CA; Bitzer GJ; Bevere JR; Barbier M; Damron FH
    Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318136
    [No Abstract]   [Full Text] [Related]  

  • 79. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Acellular and whole cell pertussis vaccines protect against the lethal effects of intracerebral challenge by two different T-cell dependent humoral routes.
    Wiertz EJ; Walvoort HC; Van Loveren H; Van Straaten-Van De Kappelle I; Van Der Gun JW; Kreeftenberg JG
    Biologicals; 1990 Jul; 18(3):173-80. PubMed ID: 2257130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.